Arcus Biosciences, Inc. (RCUS) NYSE
23.87
-1.805(-7.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
23.87
-1.805(-7.03%)
Currency In USD
| Market Cap | 2.56B |
| Enterprise Value | 2.44B |
| P/E Ratio | -8.11 |
| PEG Ratio | -0.35 |
| Price/Sales Ratio | 10.18 |
| Price/Book Ratio | 5.71 |
| Enterprise/Revenue | 9.75 |
| Enterprise/EBITDA | -6.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.56 |
| Operating Margin | -1.69 |
| Return On Assets | -0.37 |
| Return On Equity | -0.69 |
| Revenue | 247M |
| Revenue/Share | 1.88 |
| Gross Profit | 237M |
| EBITDA | -335M |
| Net Income | -353M |
| Diluted EPS | -3.29 |
| Total Cash | 822M |
| Total Cash/Share | 6.56 |
| Total Debt | 100M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 4.04 |
| Book Value Per Share | 4.18 |
| 52-Week Change | 158.84 |
| 52-Week High | 28.72 |
| 52-Week Low | 7.91 |
| Moving Average 50 Days | 23.7 |
| Moving Average 200 Days | 20.09 |
| Average Volume | 1.16M |
| Shares Outstanding | 100.67M |
| % Held by Institutions | 110.87 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |